Davos 2023
Technology to watch: 5 key trends for 2023
Green hydrogen and nuclear fusion technology will be developing fast this year, as will gene editing, quantum computing and artificial intelligence
Greta Keenan
Greta is a science and technology enthusiast with a specialism in communicating science to different audiences. As Strategic Impact and Communications Lead for the Forum's Centre for the Fourth Industrial Revolution (C4IR), Greta curates the impact narrative of the C4IR platforms, network of centres and tech start-up communities.
Prior to joining the Forum in August 2019, she worked at New Scientist magazine, the Okinawa Institute of Science and Technology in Japan, and the Francis Crick Institute.
Most Popular
Emerging Technologies
Emerging technologies: 10 years of top tech trends and how they've changed the world
Not all the emerging technologies of the past 10 years have come of age. Here are just a few of the biggest emerging technologies and what happened to them.
COVID-19
COVID-19: Top science stories of the week, from paused vaccine trial to immune profile of infected children
Scientists probe why a small number of children develop severe hyperinflammatory disorders after COVID infection - the top coronavirus science news of the week.
COVID-19
Saliva testing and molecular PPE - this week's top COVID-19 science stories
Saliva testing; reaction to Russia's vaccine announcement; and 'molecular PPE' - our pick of the week's science storied on the coronavirus pandemic.
COVID-19
COVID-19: Top science stories of the week, from early vaccine success to claims of new treatment
Oxford-AstraZeneca and CanSino Biologics vaccines show early success; new treatment claims to reduce the risk of severe disease; and Symptom app reveals six distinct types of COVID-19.
COVID-19
COVID-19: Top science stories of the week
In this round-up: Beijing approves experimental vaccine for military use and why people who test negative for antibodies may still be immune to reinfection from COVID-19.
COVID-19
COVID-19: Top science stories of the week, including new diabetes link and the latest Beijing outbreak
Including a possible new diabetes link and the genome sequence of the virus behind the latest Beijing outbreak, these are some of latest coronavirus science stories.
COVID-19
COVID-19: Top science stories of the week, from asymptomatic spreading to surface risk within households
Good news for households with self-isolating individuals: new research out this week suggests that the risk of coronavirus transmission via household surfaces is relatively low.
COVID-19
COVID-19 has disrupted addiction treatment: a neuroscientist answers our questions
Many of the services and treatments available to people recovering from drug addiction have been disrupted by the COVID-19 pandemic, putting thousands of lives at risk.
COVID-19
A second wave could lead to a 'public outcry' for digital tracing - government and business leaders on managing the coronavirus crisis
A second wave of the coronavirus pandemic could prompt the public to abandon privacy fears and call for the use of more widespread tracing technology, Prime Minister Netanyahu said.
COVID-19: Top science stories of the week, from old antibodies to new vaccines
A round-up of the most significant stories, as scientists battle to better understand and treat the coronavirus.
COVID-19
COVID-19: Top science stories of the week, from genetics to herd immunity
A round-up of the most significant science stories as scientists battle to better understand and treat the coronavirus.
COVID-19
COVID-19: Top science stories of the week, from twins to pollution
A round-up of the most significant science stories as scientists battle to better understand and treat the coronavirus.
COVID-19
COVID-19: a new human vaccine trial begins, and other top science stories of the week
Many infected with COVID-19 may be asymptomatic; early success in Chinese vaccine trials on monkeys; human trials of COVID-19 vaccine begin in the UK.
COVID-19
COVID-19: A new drug is tested, and other top science stories of the week
Worryingly low levels of antibodies have been found in recovered patients; a new drug begins clinical trials; and could sewage help us track new outbreaks?